This preview shows page 1. Sign up to view the full content.
Unformatted text preview: might these physiological changes result in an increased concentration of serum lipids? 3) In addition to the dysregulation of lipids derived from fatty acids, an upregulation of HGMCoA reductase is often found in patients with chronic kidney disease. What does this cause? How could it be treated? 4) It is possible (if not likely) that dyslipidemia can further the progression of kidney disease. However, of even greater concern is the observation that dyslipidemia associated with kidney disease can increase a patients risk of cardiovascular disease. Consider how this is possible and how the risks differ from the normal population....
View Full Document
- Spring '12